Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK claims successes in meeting cancer and CVD mortality reduction targets

This article was originally published in Clinica

Executive Summary

England is claiming early successes in meeting its targets for reducing cancer- and cardiovascular disease-related mortality among the under-75s. The annual update announced today by the Department of Health, which includes 2005-07 data, features: an 18.2% fall (since the baseline) in three-year average mortality rates for cancer, which is said to be on course to meet the 20% reduction target by 2009-11; and a 44% cut in three-year average mortality rates for circulatory diseases, thereby meeting ahead of schedule the minimum target of 40% by 2009-11, claims the DH.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel